… 28/35 (P < 0.00001) in vaccine groups compared to placebo controls. … that the current
COVID-19 vaccine candidates are safe, … , evaluation, and clinical application of COVID-19 vaccine. …

… favorable safety and tolerability profile of the COVID-19 vaccines among persons with rare
… tolerability of the COVID-19 vaccines in people with rare autoimmune diseases of the CNS . …

… -19 in individuals 16 years of age or older. The biggest vaccination campaign in world …
conducting ongoing monitoring of COVID-19 vaccine reactivity in people vaccinated in the United …

… on prior vaccine experience and data from the COVID-19 vaccine clinical … tolerability of
COVID-19 vaccines among PwE and the causes for vaccine hesitation among non-vaccinated …

… In conclusion, we found that the Ad5 vectored COVID-19 vaccine is tolerable and … -vaccination,
and rapid, specific T-cell responses were noted from day 14 after one shot of the vaccine. …

… vectorbased or mRNA-based COVID-19 vaccines,5 a pathogenic link and, … tolerability of
COVID-19 vaccines in people with antiphospholipid antibodies, we surveyed 102 vaccinated …

… vaccination”, and “clinical trial”; no language restrictions were applied. To our knowledge,
no data from human clinical trials of COVID-19 vaccine by … of COVID-19 candidate vaccines (…

… COVID-19 vaccines are currently recommended for people with myasthenia gravis (MG),
there is no data regarding the safety of the vaccines … tolerability data of any COVID-19 vaccine …

… and kidney transplant recipients coronavirus disease 2019 (COVID-19)-associated mortality
… and safe COVID-19 vaccines is of great importance for these patients. Two mRNA vaccines …

… We present a first-in-human study of intranasal COVID-19 vaccination with an adenovirus-vectored
vaccine. Reactogenicity was acceptable at all doses but immunogenicity was …